A carregar...
Low‐dose immune tolerance induction for children with hemophilia A with poor‐risk high‐titer inhibitors: A pilot study in China
BACKGROUND: Immune tolerance induction (ITI) therapy is currently unaffordable in China. Management of hemophilia A children with high‐titer inhibitor is therefore a challenge. AIM: To describe the ITI strategy using plasma‐derived factor VIII/von Willebrand factor concentrate (pdFVIII/VWF) +/− immu...
Na minha lista:
| Publicado no: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6781932/ https://ncbi.nlm.nih.gov/pubmed/31624794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12248 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|